Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €6.31 EUR
Change Today +0.393 / 6.65%
Volume 0.0
SH11 On Other Exchanges
Symbol
Exchange
Berlin
As of 2:01 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

genesis healthcare inc (SH11) Snapshot

Open
€6.31
Previous Close
€5.91
Day High
€6.31
Day Low
€6.31
52 Week High
01/20/15 - €7.93
52 Week Low
10/10/14 - €4.72
Market Cap
981.6M
Average Volume 10 Days
30.0
EPS TTM
--
Shares Outstanding
73.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENESIS HEALTHCARE INC (SH11)

genesis healthcare inc (SH11) Related Bloomberg News

View More Bloomberg News

genesis healthcare inc (SH11) Related Businessweek News

No Related Businessweek News Found

genesis healthcare inc (SH11) Details

Genesis HealthCare, Inc., together with its subsidiaries, provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company offers sub-acute care, and rehabilitative and specialty healthcare skilled nursing care services; and room and board, and assistance with activities of daily living. It also provides rehabilitation therapy services, including physical therapy, occupational therapy, and/or speech language pathology services; hospice care and home health services; and private duty care services. As of March 24, 2015, the company owned or leased approximately 500 skilled nursing and assisted/senior living facilities in 34 states. Genesis Healthcare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

Founded in 2003

genesis healthcare inc (SH11) Top Compensated Officers

Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $372.3K
Compensation as of Fiscal Year 2014.

genesis healthcare inc (SH11) Key Developments

Genesis Healthcare, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Earnings Guidance for the Year Ending December 31, 2015

Genesis Healthcare, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net revenues of $1,419,475,000 against $1,200,651,000 a year ago. Loss before income tax benefit was $37,633,000 against $30,952,000 a year ago. Loss from continuing operations was $33,214,000 or $0.20 per basic and diluted share against $30,856,000 or $0.63 per basic and diluted share a year ago. Net loss attributable to company was $19,186,000 or $0.22 per basic and diluted share against $32,256,000 or $0.65 per basic and diluted share a year ago. Adjusted revenues were $1,410,261,000 against $1,403,225,000 a year ago. Adjusted income before income tax benefit was $34,951,000 against $22,828,000 a year ago. Income from continuing operations was $22,522,000 or $0.14 per basic and diluted share against $22,674,000 a year ago. Net income attributable to company was $15,782,000 against $21,711,000 a year ago. EBITDA was $145,049,000 against $128,690,000 a year ago. Adjusted EBITDA was $76,557,000 against $69,602,000 a year ago. EBITDAR was $184,008,000 against $161,599,000 a year ago. Adjusted EBITDAR was $197,974,000 against $187,100,000 a year ago. Pro forma adjusted EBITDAR was $197,974,000 against $187,100,000 a year ago. Pro forma adjusted EBITDA was $76,557,000 against $69,602,000 a year ago. For the six months, the company reported net revenues of $2,762,476,000 against $2,387,195,000 a year ago. Loss before income tax benefit was $161,643,000 against $74,494,000 a year ago. Loss from continuing operations was $151,576,000 or $1.58 per basic and diluted share against $71,644,000 or $1.44 per basic and diluted share a year ago. Net loss attributable to company was $131,752,000 or $1.60 per basic and diluted share against $76,423,000 or $1.53 per basic and diluted share a year ago. Net cash used in operating activities was $7,729,000 against net cash provided by operating activities of $36,361,000 a year ago. Adjusted revenues were $2,812,787,000 against $2,795,486,000 a year ago. Income before income tax benefit was $45,352,000 against $28,425,000 a year ago. Income from continuing operations was $12,736,000 or $0.21 per basic and diluted share against $36,805,000 a year ago. Net loss attributable to company was $28,481,000 against income of $33,990,000 a year ago. EBITDA was $283,977,000 against $244,146,000 a year ago. Adjusted EBITDA was $142,778,000 against $129,550,000 a year ago. EBITDAR was $359,355,000 against $309,854,000 a year ago. Adjusted EBITDAR was $383,339,000 against $361,749,000 a year ago. Pro forma adjusted EBITDAR was $383,339,000 against $361,749,000 a year ago. Pro forma adjusted EBITDA was $142,778,000 against $129,550,000 a year ago. For the year ending December 31, 2015, the company reaffirms its previously announced 2015 adjusted EBITDAR guidance of $755.0 million to $770.0 million and adjusted EBITDA of $267.6 million to $282.6 million.  In connection with further refinement to projected depreciation and amortization expense, the company is adjusting its previous 2015 net income from continuing operations on a diluted basis from a range of $0.29 to $0.34 per share to a revised range of $0.34 to $0.39 per share. Net revenues in the range of $5,684.197 million to $5,764.197 million, adjusted net revenues in the range of $5,658.438 million to $5,738.438 million, loss before income tax benefit in the range of $235.677 million to $222.494 million, adjusted income before income tax benefit in the range of $87.154 million to $100.337 million, loss from continuing operations is in the range of $141.406 million to $133.496 million, adjusted income from continuing operations is in the range of $52.292 million to $60.202 million, diluted loss per share is in the range of $0.91 to $0.86, adjusted diluted earnings per share is in the range of $0.34 to $0.39, EBITDA in the range of $595.026 million to $610.013 million and adjusted EBITDA in the range of $752.900 million to $767.887 million. Depreciation and amortization expense is in the range of $234.511 million to $235.515 million, adjusted depreciation and amortization expense is in the range of $94.512 million to $95.516 million, interest expense is in the range of $507.203 million to $508.003 million, adjusted interest expense is in the range of $85.952 million to $86.752 million, negative income tax expense is in the range of $94.271 million to $88.998 million and adjusted income tax expense is in the range of $34.862 million to $40.135 million.

Genesis Healthcare, Inc. to Report Q2, 2015 Results on Aug 06, 2015

Genesis Healthcare, Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 06, 2015

Genesis Healthcare, Inc., Q2 2015 Earnings Call, Aug 07, 2015

Genesis Healthcare, Inc., Q2 2015 Earnings Call, Aug 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SH11:GR €6.31 EUR +0.393

SH11 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $27.73 USD +0.11
Kindred Healthcare Inc $20.63 USD -0.04
National HealthCare Corp $60.93 USD -0.28
Ensign Group Inc/The $47.21 USD +0.23
View Industry Companies
 

Industry Analysis

SH11

Industry Average

Valuation SH11 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENESIS HEALTHCARE INC, please visit www.genesishcc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.